Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Study With Self-administered Rocatinlimab in Adolescent and Adult Participants With Moderate-to-severe Atopic Dermatitis

ClinicalTrials.gov ID: NCT06224192

Public ClinicalTrials.gov record NCT06224192. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 3:27 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multicenter, Randomized, Open-label, Performance Study With Self-administered Subcutaneous Rocatinlimab (AMG 451) in Adolescent and Adult Subjects With Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Outpost)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of this study is to assess successful self-administration of rocatinlimab subcutaneously using devices for injection.

Study identification

NCT ID
NCT06224192
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Amgen
Industry
Enrollment
151 participants

Conditions and interventions

Interventions

Combination Product

Eligibility (public fields only)

Age range
12 Years to 100 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2, 2024 (Actual)
Primary completion
Apr 11, 2025 (Actual)
Completion
Mar 16, 2026 (Actual)
Last update posted
Mar 25, 2026

2024 – 2026

United States locations

U.S. sites
22
U.S. states
13
U.S. cities
22
Facility City State ZIP Site status
Kern Research Inc Bakersfield California 93301 —
Long Beach Research Institute Long Beach California 90805 —
Dermatology Research Associates Los Angeles California 90045 —
Havana Research Institute Inc Pasadena California 91105 —
Integrative Skin Science and Research Sacramento California 95815 —
Direct Helpers Research Center Hialeah Florida 33012 —
Anchor Medical Research Miami Florida 33176 —
Hamilton Research, LLC Alpharetta Georgia 30022 —
Treasure Valley Medical Research Boise Idaho 83706 —
Dermatology and Skin Cancer Center Leawood Leawood Kansas 66211 —
Excel Clinical Research Las Vegas Nevada 89109 —
Las Vegas Clinical Trials North Las Vegas Nevada 89030 —
Skin Cancer and Dermatology Institute Reno Nevada 89509 —
The Skin Surgery Center for Clinical Research Winston-Salem North Carolina 27103 —
Bexley Dermatology Research Bexley Ohio 43209 —
Apex Clinical Research Center LLC Mayfield Heights Ohio 44124 —
Essential Medical Research LLC Tulsa Oklahoma 74137 —
Health Concepts Rapid City South Dakota 57702 —
Cumberland Skin Center Hermitage Tennessee 37076 —
Sms Clinical Research Limited Liability Company Mesquite Texas 75149 —
Texas Dermatology Research Center Plano Texas 75025 —
Virginia Dermatology and Skin Cancer Center Norfolk Virginia 23502 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 25 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06224192, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 25, 2026 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06224192 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →